205 related articles for article (PubMed ID: 33614938)
1. Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma.
Kim E; Obermeyer I; Rubin N; Khariwala SS
Laryngoscope Investig Otolaryngol; 2021 Feb; 6(1):109-115. PubMed ID: 33614938
[TBL] [Abstract][Full Text] [Related]
2. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
[TBL] [Abstract][Full Text] [Related]
3. Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety.
Hanks JE; Kovatch KJ; Ali SA; Roberts E; Durham AB; Smith JD; Bradford CR; Malloy KM; Boonstra PS; Lao CD; McLean SA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):520-529. PubMed ID: 32041486
[TBL] [Abstract][Full Text] [Related]
4. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
Monroe MM; Pattisapu P; Myers JN; Kupferman ME
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for positive sentinel lymph nodes in head and neck melanoma - a survival analysis.
Bonachela NL; Kowalski LP; Santos ABO
Braz J Otorhinolaryngol; 2021; 87(1):103-109. PubMed ID: 33272834
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
7. A definitive role for sentinel lymph node mapping with biopsy for cutaneous melanoma of the head and neck.
Kelly J; Fogarty K; Redmond HP
Surgeon; 2009 Dec; 7(6):336-9. PubMed ID: 20681375
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
10. Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.
Appleton SE; Fadel Z; Williams JS; Bezuhly M
Plast Reconstr Surg; 2018 Jun; 141(6):1529-1540. PubMed ID: 29579032
[TBL] [Abstract][Full Text] [Related]
11. Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma.
Schmalbach CE; Nussenbaum B; Rees RS; Schwartz J; Johnson TM; Bradford CR
Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):61-5. PubMed ID: 12525196
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
13. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma.
Doting MH; Hoekstra HJ; Plukker JT; Piers DA; Jager PL; Tiebosch AT; Vermey A; Schraffordt Koops H
Eur J Surg Oncol; 2002 Sep; 28(6):673-8. PubMed ID: 12359207
[TBL] [Abstract][Full Text] [Related]
14. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
15. The role of sentinel lymph node biopsy for thin cutaneous melanomas of the head and neck.
Kupferman ME; Kubik MW; Bradford CR; Civantos FJ; Devaney KO; Medina JE; Rinaldo A; Stoeckli SJ; Takes RP; Ferlito A
Am J Otolaryngol; 2014; 35(2):226-32. PubMed ID: 24439782
[TBL] [Abstract][Full Text] [Related]
16. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy for cutaneous melanoma: a 6 years study.
Lima Sánchez J; Sánchez Medina M; García Duque O; Fiúza Pérez M; Carreteri Hernández G; Fernández Palácios J
Indian J Plast Surg; 2013 Jan; 46(1):92-7. PubMed ID: 23960312
[TBL] [Abstract][Full Text] [Related]
19. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
[TBL] [Abstract][Full Text] [Related]
20. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
